Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias Juan Pedro-Botet; Juan F. Ascaso; Mariano Blasco; Ángel Brea; Ángel Díaz; Antonio Hernández-Mijares; Xavier Pintó; Jesús Millán;

Hypertriglyceridemia (>¿150 mg/dL) as a marker of cardiovascular risk José López-Miranda;

New drugs for treating dyslipidemias. From small molecules to small interfering RNAs Lluís Masana; Daiana Ibarretxe;